SI
SI
discoversearch

Biotech / Medical
ProMetic Life Sciences
An SI Board Since April 2016
Posts SubjectMarks Bans Symbol
91 7 0 PLI
Emcee:  axial Type:  Moderated
PROMETIC LIFE SCIENCES — prometic.com

ProMetic is a biopharmaceutical corporation with globally recognized expertise in bioseparation and uses its own affinity technology for the development of best in class plasma-derived therapeutics. ProMetic is also active in developing its own novel small molecule therapeutics products. Headquartered in Laval, Canada, ProMetic has a global presence through its various sites in the UK and USA, providing both manufacturing and R&D capability. These strategic locations facilitate ProMetic’s growth globally and supports all business activity in American, European and Asian markets. ProMetic is publicly traded on TSX (Symbol: PLI) and OTCQX (Symbol: PFSCF).

ProMetic has developed core competencies in strategic fields, including:
  • Purification of biologics
  • Drug development
  • Proteomics
  • Elimination of pathogens
The business is now focused on developing its range of therapeutics from both its plasma-derived and small-molecule platform.
___________________________________________

WELCOME! —This is a moderated board. No spam, ad hominem attacks or flaming. One warning. Next time you're out, with your posts deleted.
___________________________________________
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
91PROMETIC’S PBI-4050 SHOWN TO REDUCE LIVER DAMAGE AND FIBROSIS IN HIGH-FAT DIET axial-last Thursday
90FDA confirms Prometic's PBI-4050 IPF clinical trial design FDA concurs witaxial-last Tuesday
89PROMETIC RECEIVES $9.5 MILLION PURCHASE ORDER FROM MULTINATIONAL CLIENT ' Laxial-April 7
88Jim thanks for staying on top of this!Leo Fisher-April 7
87Analysis — From the short side, i.e. Bloom Burton — bloomburton.com Hat tip toaxial-April 5
86Analysis — April 2017: Echelon and Hybridian docdro.id _______________________axial-April 5
85PROMETIC COMPLETES THE FILING OF ITS PLASMINOGEN BIOLOGICS LICENSE APPLICATION (axial-April 5
84Q4 2016 PROMETIC LIFE SCIENCES INC EARNINGS CALL TEXT version of Transcript [Naxial1April 2
83PROMETIC CC PRESENTATION DOCUMENT (PDF) Jimaxial-March 31
82From RBC — 31 March 2017 From ScotiaBank — 31 March 2017 Jimaxial-March 31
81PROMETIC REPORTS ITS 2016 FOURTH QUARTER AND YEAR END HIGHLIGHTS AND FINANCIAL Raxial-March 31
80PROMETIC AND SHENZHEN ROYAL ASSET MANAGEMENT (SRAM) TO ESTABLISH A JOINT VENTURaxial1March 30
79There's no obvious sign of trouble ahead, but the stock always seems to holdaxial-March 24
78Sounds like we are on track for Q4!Leo Fisher-March 24
77PROMETIC ENTERS INTO BINDING AGREEMENT TO SECURE $25 MILLION FOLLOW-ON FINANCINaxial-March 24
76PROMETIC TO REPORT ITS FOURTH QUARTER AND YEAR-END 2016 FINANCIAL RESULTS AND HOaxial-March 23
75Trump chooses Gottlieb to run FDA; Pharma breathes sigh of relief 'U.S. Praxial-March 11
74Excerpt : 2017 RBC Capital Markets’ Healthcare Conference Unconfirmed — no linkaxial-March 6
73Prometic video — Progress update to March 2017 here. Jimaxial1March 5
72US FDA GRANTS ORPHAN DRUG DESIGNATION TO PROMETIC’S PBI-4050 DRUG FOR THE TREATMaxial1March 3
71Interesting article posted today on PLI website: -Early evidence of efficacy ofLeo Fisher1February 22
70NASDAQ and PROMETIC The following is a recent email sent to a Prometic investoraxial-February 20
69Pediatric Priority Review Voucher — Regulatory Explainer: Everything You Need taxial-February 15
682016 article — paid plasma collection in Canada Blood money: Legislated out of axial-February 15
67CALIFORNIA CAPITAL EQUITY, LLC ACQUIRES 44 MILLION PROMETIC SHARES THROUGH THE Eaxial-February 6
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2017 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.